Skip to content

APOTHEEK OPPUURS: what changed

BE 0841.843.204NACE 47.730, Retail sale of pharmaceutical productsOther company

Position among the sector peers

What moved between 2024 and 2025

Net result for the year
€67,484
2024 · €63,771+€3,713
Equity
€372,493
2024 · €481,358-€108,865
Cash
€126,223
2024 · €114,081+€12,142
Balance sheet total
€658,826
2024 · €687,448-€28,622

Largest movements

2024 to 2025
Assets
  • Current investments -€33,267

    down €33,267 (-13.1%), from €254,774 to €221,507

  • Cash +€12,142

    up €12,142 (+10.6%), from €114,081 to €126,223

    mainly Other debts (+€104,931) and Net result for the year (+€67,484)

Equity and liabilities
  • Reserves -€108,865

    down €108,865 (-23.2%), from €468,958 to €360,093

  • Other debts +€104,931

    up €104,931 (+96.4%), from €108,825 to €213,756

  • Debts after one year -€20,651

    down €20,651 (-100%), from €20,651 to €0

Income statement
  • Financial charges -€3,572

    down €3,572 (-33.9%), from €10,545 to €6,973

  • Financial income +€1,963

    up €1,963 (+140%), from €1,397 to €3,360

Change in the result, 2024 to 2025

effect on the result

For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.

Result 2024 €63,771
Gross operating margin -€100
Staff costs -€1,390
Depreciation +€836
Other operating charges +€162
Financial income +€1,963
Financial charges +€3,572
Taxes -€1,331
Result 2025 €67,484
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.

From operations +€185,045
Investment +€25,637
Financing -€198,541
Cash 2024 €114,081
Net result for the year +€67,484
Depreciation +€12,273
Stocks and contracts +€454
Receivables within one year +€1,835
Deferred charges and accrued income +€565
Trade debts +€662
Tax, wage and social debts -€3,034
Other debts +€104,931
Accrued charges and deferred income -€123
Investment in fixed assets (net) -€7,630
Current investments +€33,267
Debts after one year -€20,651
Current portion of long-term debt -€1,541
Contributions, distributions and other -€176,348
Cash 2025 €126,223
brings cash intakes cash out
Every line side by side 46 lines
Line Code 2024 2025 Change %
Total assets 20/58 €687,448 €658,826 -€28,622 -4.2%
Fixed assets 21/28 €117,729 €113,085 -€4,643 -3.9%
Tangible fixed assets 22/27 €117,729 €113,085 -€4,643 -3.9%
Land and buildings 22 €104,400 €98,200 -€6,200 -5.9%
Plant, machinery and equipment 23 €11,610 €13,838 +€2,228 +19.2%
Furniture and vehicles 24 €1,719 €1,048 -€671 -39.1%
Current assets 29/58 €569,719 €545,740 -€23,979 -4.2%
Stocks and contracts in progress 3 €122,705 €122,251 -€454 -0.4%
Stocks 30/36 €122,705 €122,251 -€454 -0.4%
Amounts receivable within one year 40/41 €65,603 €63,768 -€1,835 -2.8%
Trade receivables 40 €61,049 €61,671 +€622 +1.0%
Other amounts receivable 41 €4,554 €2,097 -€2,457 -53.9%
Current investments 50/53 €254,774 €221,507 -€33,267 -13.1%
Cash at bank and in hand 54/58 €114,081 €126,223 +€12,142 +10.6%
Deferred charges and accrued income 490/1 €12,556 €11,991 -€565 -4.5%
Total equity and liabilities 10/49 €687,448 €658,826 -€28,622 -4.2%
Equity 10/15 €481,358 €372,493 -€108,865 -22.6%
Contributions 10/11 €12,400 €12,400 = 0.0%
Reserves 13 €468,958 €360,093 -€108,865 -23.2%
Distributable reserves 133 €468,958 €360,093 -€108,865 -23.2%
Profit (loss) carried forward 14 €0 €0 =
Amounts payable 17/49 €206,090 €286,332 +€80,243 +38.9%
Amounts payable after more than one year 17 €20,651 €0 -€20,651 -100%
Financial debts 170/4 €20,651 €0 -€20,651 -100%
Amounts payable within one year 42/48 €181,746 €282,763 +€101,017 +55.6%
Current portion of amounts payable after more than one year 42 €22,193 €20,651 -€1,541 -6.9%
Trade debts 44 €36,463 €37,125 +€662 +1.8%
Suppliers 440/4 €36,463 €37,125 +€662 +1.8%
Taxes, remuneration and social security 45 €14,265 €11,231 -€3,034 -21.3%
Taxes 450/3 €8,153 €6,718 -€1,434 -17.6%
Remuneration and social security 454/9 €6,112 €4,512 -€1,600 -26.2%
Other amounts payable 47/48 €108,825 €213,756 +€104,931 +96.4%
Accrued charges and deferred income 492/3 €3,693 €3,570 -€123 -3.3%
Remuneration, social security and pensions 62 €32,336 €33,726 +€1,390 +4.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €13,110 €12,273 -€836 -6.4%
Other operating charges 640/8 €690 €528 -€162 -23.5%
Gross operating margin 9900 €143,703 €143,603 -€100 -0.1%
Operating profit (loss) 9901 €97,566 €97,075 -€491 -0.5%
Financial income 75/76B €1,397 €3,360 +€1,963 +140%
Recurring financial income 75 €1,397 €3,360 +€1,963 +140%
Financial charges 65/66B €10,545 €6,973 -€3,572 -33.9%
Recurring financial charges 65 €10,545 €6,973 -€3,572 -33.9%
Profit (loss) for the period before taxes 9903 €88,418 €93,462 +€5,044 +5.7%
Income taxes 67/77 €24,648 €25,979 +€1,331 +5.4%
Profit (loss) for the period 9904 €63,771 €67,484 +€3,713 +5.8%
Profit (loss) for the period to be appropriated 9905 €63,771 €67,484 +€3,713 +5.8%

Value

latest balance sheet 31-12-2025 · indication, not a valuation or advice

Indicative value of the equity

Indication, not a valuation or advice
€411,693 to €501,872

Midpoint €449,268 · 50% capitalised earnings, 50% adjusted equity

Capitalisation rate 12% result over 3 years earnings weight 50%

Adjusted equity €372,493
Capitalised earnings €450,893 to €631,250
Indication €411,693 to €501,872

Adjusted equity

balance sheet 31-12-2025
Equity (10/15)
€372,493
Revaluation of assets
€0
Deferred tax on the revaluation
€0
Other adjustment
€0
Adjusted equity
€372,493

Capitalised earnings

net result for the year (9904)
2025
€67,484
2024
€63,771
2023
€58,120
2022
€70,915
2021
€43,854
Average result
€63,125
Divided by the capitalisation rate
14% / 12% / 10%
Capitalised earnings
€450,893 / €526,042 / €631,250

Limits of the indication

  • Checked holds no market prices or comparable transactions.
  • Anything after the latest accounts and items off the balance sheet (guarantees, leases, disputes) are left out.
  • Checked does not know the real value of buildings, stock and receivables. Enter your own revaluation or adjustment for it.
  • The owner's role in the business, synergies for a buyer and the tax consequences of a sale are left out.

For a valuation to base a decision on, go to a company auditor or a certified accountant.

Calculation and sources

Source: filed annual accounts (NBB) and main activity (KBO). The movements compare the financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. The value is an indication, not a valuation or advice. Prepared on 10 November 2026 via checked.be.